Proceedings of the National Academy of Sciences · 2000 · 235 citations · 30 references
Life SciencesNeurobiologyNeuroscienceCell SignalingMolecular NeuroscienceSignal TransductionAddictionAddiction NeurobiologyDopaminergic SignalingNeurochemical Signaling PathwaysNeuromodulationNeurotransmissionDopamine D1-like ReceptorsDopamine D2-like ReceptorsDopaminergic PathwaysPhosphatase Enzyme ActivityPositive FeedbackPositive Feedback MechanismsPositive Feedback SystemsProtein Phosphatase 2A Regulation
Dopamine and cAMP-regulated phosphoprotein of M(r) 32,000 (DARPP-32) plays an obligatory role in most of the actions of dopamine. In resting neostriatal slices, cyclin-dependent kinase 5 (Cdk5) phosphorylates DARPP-32 at Thr-75, thereby reducing the efficacy of dopaminergic signaling. We report here that dopamine, in slices, and acute cocaine, in whole animals, decreases the state of phosphorylation of striatal DARPP-32 at Thr-75 and thereby removes this inhibitory constraint. This effect of dopamine is achieved through dopamine D1 receptor-mediated activation of cAMP-dependent protein kinase (PKA). The activated PKA, by decreasing the state of phosphorylation of DARPP-32-Thr-75, de-inhibits itself. Dopamine D2 receptor stimulation has the opposite effect. The ability of activated PKA to reduce the state of phosphorylation of DARPP-32-Thr-75 is apparently attributable to increased protein phosphatase-2A activity, with Cdk5 being unaffected. Together, these results indicate that via positive feedback mechanisms, Cdk5 signaling and PKA signaling are mutually antagonistic.
30
Conversion of p35 to p25 deregulates Cdk5 activity and promotes neurodegeneration
Gentry N. Patrick, Lawrence Zukerberg, Margareta Nikolić et al. · Nature · 1999 · 1.5K citations
CC Ouimet, P. E. Miller, HC Hemmings et al. · Journal of Neuroscience · 1984 · 656 citations · Full text